Clinical trials suggest GLP-1s may improve fertility in men with obesity

A study presented at the Endocrine Society's annual meeting suggests that GLP-1 medications, commonly used for weight loss and diabetes, may improve testosterone levels and sperm quality in men with obesity. The research indicates these drugs do not negatively impact male fertility.
Why it matters
Provides important health information for men considering weight-loss treatments and suggests potential benefits beyond metabolic health.
edited by Gaby Clark , reviewed by Robert Egan
Reports on scientific findings from a medical conference without bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in